Patent · US Expired

Pharmaceutical compositions with wound healing or anti-complementary activity comprising a dextran derivative

US7101863B2 · kind B2 · utility

2Cited by
3References
11Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 13, 2001
Grant dateSep 5, 2006
Priority date
Expiry dateJul 29, 2023

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC08B37/0021
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention concerns pharmaceutical compositions with wound healing or anti-complementary activity, and their uses, said compositions comprising, (1) at least a dextran derivative of general formula DMCaBbSuc, a, b, and c respectively representing the degrees of substitution in the groups MC, B and Su, wherein a≧0.6, b=0 or ≧0.1, and c=0 or ranges widely between 0.1 and 0.5 for a wound healing composition, and a≧0.3, b≧0.1 and c=0 or ranges widely between 0.1 and 0.4 for a composition with anti-complementary activity; (2) and at least a pharmaceutically acceptable carrier, said dextran derivative being present in a single unit dose or at a concentration adapted to the desired wound healing or anti-complementary activity.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.